基本信息
浏览量:9
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Takeya ADACHI, M.D., Ph.D. is a Project Assistant Professor of Department of Dermatology, Keio University School of Medicine/Keio Frontier Research & Education Collaborative Square (K-FRECS) at Tonomachi, Keio University/Kyoto Prefectural University of Medicine. He is the president of the NPO United Japanese-researchers Around-the-world (UJA); the vice-president/founder of the NPO Cheiron Initiative; a Japanese Dermatological Association Board Certified Dermatologist; a Japanese Society of Allergology Board Certified Allergologist; a Designated Physician for Rare/Intractable Diseases; and has received a certificate in Health Technology Assessment Expert Program from the University of Tokyo Graduate School of Public Health.
After he received M.D. in Keio University School of Medicine, Tokyo, Japan, he majored in medicine to shed light on the novel immunological insights in the context of skin T cell homeostasis and lymphoma (Adachi et al.: Nat. Med. 2015) and received Ph.D. in Keio University Graduate School of Medicine in 2016. His research interests include dermatology, immunology, allergy as well as rare and intractable drug hypersensitivities, and since 2020, he has promoted international collaborative research with the Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR3572, Institut de Biologie Moléculaire et Cellulaire (IBMC), Université de Strasbourg, France, as its former Professeur invité.
Upon his experience as a visiting scientist at the secretariat of Human Frontier Science Program (HFSP), a Program Officer in the Japanese governmental R&D funding agency, AMED (Adachi et al.: EJHG 2017, OJRD 2018, Springer-Nature White Paper 2019), and an Interdisciplinary Scientific Committee member of the International Rare Diseases Research Consortium (IRDiRC), he is in charge of the ENGAGE Task Force supported by the Ministry of Health, Labour and Welfare of Japan to implement a national research strategy toward 2030 for allergy/immunology (Adachi et al.: Allergol Int 2020).
Currently, he is taking the lead role in developing the Cross-Reality (XR) platform and novel impact analysis (Adachi et al.: Allergy 2022), promoting science without borders to form a society in which people live long, healthy lives, that is.
研究兴趣
论文共 43 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Arerugi = [Allergy]no. 3 (2024): 268-278
Katsunori Masaki,Masafumi Sakashita,Yasushi Ogawa, Takenori Inomata,Keigo Kainuma,Keiko Kan-O, Sakura Sato, Mayumi Tamari, Saeko Nakajima,Hideaki Morita,Yosuke Kurashima,Masaki Futamura,
Arerugi = [Allergy]no. 4 (2024): 329-339
RESPIRATORY INVESTIGATIONno. 1 (2024): 113-120
Allergyno. 4 (2023): 1056-1060
International journal of environmental research and public healthno. 6 (2023): 4732-4732
Kohei Homma, Yutaka Kuroki, Kohei Koshida, Shun Ikemoto, Tadayuki Akagi,Kazuhito Morioka,Takeya Adachi, Yukako Ono
引用0浏览0引用
0
0
JOURNAL OF DERMATOLOGYno. 1 (2022): e22-e23
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn